

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.16805006 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.16805006 |
| 3 | COPI coating of Golgi vesicle (GO:0048205) | 4.09677768 |
| 4 | Golgi transport vesicle coating (GO:0048200) | 4.09677768 |
| 5 | positive regulation of extracellular matrix organization (GO:1903055) | 3.90543944 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.84145881 |
| 7 | regulation of cholesterol homeostasis (GO:2000188) | 3.84103736 |
| 8 | regulation of extracellular matrix disassembly (GO:0010715) | 3.82395794 |
| 9 | regulation of cholesterol storage (GO:0010885) | 3.72542792 |
| 10 | protein retention in ER lumen (GO:0006621) | 3.72171370 |
| 11 | barbed-end actin filament capping (GO:0051016) | 3.72108037 |
| 12 | apoptotic cell clearance (GO:0043277) | 3.67386144 |
| 13 | valine metabolic process (GO:0006573) | 3.61154813 |
| 14 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.56836723 |
| 15 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.55550222 |
| 16 | actin filament depolymerization (GO:0030042) | 3.50725042 |
| 17 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.46220068 |
| 18 | low-density lipoprotein particle clearance (GO:0034383) | 3.41672010 |
| 19 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.37744067 |
| 20 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.37744067 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 3.37713237 |
| 22 | NADH metabolic process (GO:0006734) | 3.37053236 |
| 23 | virion attachment to host cell (GO:0019062) | 3.35245629 |
| 24 | adhesion of symbiont to host cell (GO:0044650) | 3.35245629 |
| 25 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.32114976 |
| 26 | extracellular fibril organization (GO:0043206) | 3.29947120 |
| 27 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.29676471 |
| 28 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.26753104 |
| 29 | adhesion of symbiont to host (GO:0044406) | 3.25115458 |
| 30 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.22318325 |
| 31 | protein carboxylation (GO:0018214) | 3.22318325 |
| 32 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.20121546 |
| 33 | complement activation, alternative pathway (GO:0006957) | 3.17545541 |
| 34 | pinocytosis (GO:0006907) | 3.15933174 |
| 35 | fibril organization (GO:0097435) | 3.13483539 |
| 36 | negative regulation of fibrinolysis (GO:0051918) | 3.12305467 |
| 37 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.10193474 |
| 38 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.09456986 |
| 39 | mannose metabolic process (GO:0006013) | 3.05539426 |
| 40 | regulation of extracellular matrix organization (GO:1903053) | 3.03334998 |
| 41 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.97451293 |
| 42 | membrane raft organization (GO:0031579) | 2.96992064 |
| 43 | negative regulation of lipid storage (GO:0010888) | 2.93848818 |
| 44 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.93071456 |
| 45 | regulation of sequestering of triglyceride (GO:0010889) | 2.92490836 |
| 46 | positive regulation of fatty acid oxidation (GO:0046321) | 2.90527532 |
| 47 | regulation of protein activation cascade (GO:2000257) | 2.89617012 |
| 48 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.88857207 |
| 49 | proline biosynthetic process (GO:0006561) | 2.88132003 |
| 50 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.86134702 |
| 51 | fatty acid beta-oxidation (GO:0006635) | 2.85020088 |
| 52 | regulation of complement activation (GO:0030449) | 2.84372378 |
| 53 | immunoglobulin mediated immune response (GO:0016064) | 2.83799012 |
| 54 | regulation of metalloenzyme activity (GO:0048552) | 2.82207091 |
| 55 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.82118447 |
| 56 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.80151842 |
| 57 | positive regulation of sterol transport (GO:0032373) | 2.80084693 |
| 58 | positive regulation of cholesterol transport (GO:0032376) | 2.80084693 |
| 59 | fibrinolysis (GO:0042730) | 2.80032800 |
| 60 | type B pancreatic cell proliferation (GO:0044342) | 2.78790674 |
| 61 | positive regulation of cholesterol efflux (GO:0010875) | 2.78704055 |
| 62 | angiotensin maturation (GO:0002003) | 2.78519019 |
| 63 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.74585579 |
| 64 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.74503037 |
| 65 | L-phenylalanine catabolic process (GO:0006559) | 2.74503037 |
| 66 | plasma lipoprotein particle clearance (GO:0034381) | 2.73654618 |
| 67 | L-phenylalanine metabolic process (GO:0006558) | 2.73052725 |
| 68 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.73052725 |
| 69 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.72373883 |
| 70 | regulation of fibrinolysis (GO:0051917) | 2.71814561 |
| 71 | 2-oxoglutarate metabolic process (GO:0006103) | 2.71702909 |
| 72 | sulfur amino acid catabolic process (GO:0000098) | 2.71040562 |
| 73 | regulation of plasminogen activation (GO:0010755) | 2.70643621 |
| 74 | hypotonic response (GO:0006971) | 2.68991912 |
| 75 | acylglycerol homeostasis (GO:0055090) | 2.67785441 |
| 76 | triglyceride homeostasis (GO:0070328) | 2.67785441 |
| 77 | negative regulation of B cell apoptotic process (GO:0002903) | 2.67076697 |
| 78 | protein maturation by protein folding (GO:0022417) | 2.66749890 |
| 79 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.66574576 |
| 80 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.66227540 |
| 81 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.66227540 |
| 82 | regulation of cholesterol metabolic process (GO:0090181) | 2.66179740 |
| 83 | fatty acid transmembrane transport (GO:1902001) | 2.65195275 |
| 84 | ethanol oxidation (GO:0006069) | 2.64412855 |
| 85 | positive regulation of receptor recycling (GO:0001921) | 2.64220305 |
| 86 | peptide catabolic process (GO:0043171) | 2.63923140 |
| 87 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.63908846 |
| 88 | endothelial cell chemotaxis (GO:0035767) | 2.63832147 |
| 89 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.63827397 |
| 90 | regulation of triglyceride catabolic process (GO:0010896) | 2.63294981 |
| 91 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.62765440 |
| 92 | protein hydroxylation (GO:0018126) | 2.61968708 |
| 93 | peptidyl-proline hydroxylation (GO:0019511) | 2.61962237 |
| 94 | fatty acid oxidation (GO:0019395) | 2.61782225 |
| 95 | positive regulation of pseudopodium assembly (GO:0031274) | 2.60766199 |
| 96 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.60720437 |
| 97 | protein heterotrimerization (GO:0070208) | 2.60302881 |
| 98 | response to interferon-alpha (GO:0035455) | 2.60284373 |
| 99 | regulation of triglyceride metabolic process (GO:0090207) | 2.60078275 |
| 100 | lysine catabolic process (GO:0006554) | 2.59728349 |
| 101 | lysine metabolic process (GO:0006553) | 2.59728349 |
| 102 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.59548366 |
| 103 | urea metabolic process (GO:0019627) | 2.59190284 |
| 104 | urea cycle (GO:0000050) | 2.59190284 |
| 105 | collagen fibril organization (GO:0030199) | 2.59173753 |
| 106 | epoxygenase P450 pathway (GO:0019373) | 2.58366983 |
| 107 | complement activation, classical pathway (GO:0006958) | 2.58155793 |
| 108 | kynurenine metabolic process (GO:0070189) | 2.57553209 |
| 109 | lipid oxidation (GO:0034440) | 2.57106597 |
| 110 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.56967348 |
| 111 | aromatic amino acid family catabolic process (GO:0009074) | 2.56899663 |
| 112 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.56459826 |
| 113 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.56266655 |
| 114 | T cell apoptotic process (GO:0070231) | 2.55820717 |
| 115 | cell adhesion mediated by integrin (GO:0033627) | 2.54070659 |
| 116 | glyoxylate metabolic process (GO:0046487) | 2.53104044 |
| 117 | UV protection (GO:0009650) | 2.51447067 |
| 118 | protein localization to endosome (GO:0036010) | 2.49423583 |
| 119 | fatty acid catabolic process (GO:0009062) | 2.49371996 |
| 120 | stress fiber assembly (GO:0043149) | 2.48904123 |
| 121 | regulation of fatty acid oxidation (GO:0046320) | 2.48167668 |
| 122 | opsonization (GO:0008228) | 2.46746466 |
| 123 | basement membrane organization (GO:0071711) | 2.45413979 |
| 124 | negative regulation of coagulation (GO:0050819) | 2.44929200 |
| 125 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.44754433 |
| 126 | amino-acid betaine metabolic process (GO:0006577) | 2.44753295 |
| 127 | regulation of early endosome to late endosome transport (GO:2000641) | 2.44453963 |
| 128 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.44293637 |
| 129 | positive regulation of lipid catabolic process (GO:0050996) | 2.43986197 |
| 130 | indole-containing compound catabolic process (GO:0042436) | 2.43389816 |
| 131 | indolalkylamine catabolic process (GO:0046218) | 2.43389816 |
| 132 | tryptophan catabolic process (GO:0006569) | 2.43389816 |
| 133 | regulation of pseudopodium assembly (GO:0031272) | 2.42620623 |
| 134 | GDP-mannose metabolic process (GO:0019673) | 2.42270317 |
| 135 | cysteine metabolic process (GO:0006534) | 2.42128601 |
| 136 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.40887770 |
| 137 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.40344170 |
| 138 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.39829927 |
| 139 | negative regulation of innate immune response (GO:0045824) | 2.38361506 |
| 140 | proline metabolic process (GO:0006560) | 2.38275675 |
| 141 | carnitine shuttle (GO:0006853) | 2.38076069 |
| 142 | cellular glucuronidation (GO:0052695) | 2.37955375 |
| 143 | skin morphogenesis (GO:0043589) | 2.37952167 |
| 144 | germinal center formation (GO:0002467) | 2.37362743 |
| 145 | cellular response to interferon-alpha (GO:0035457) | 2.37338413 |
| 146 | renal filtration (GO:0097205) | 2.36755198 |
| 147 | regulation of natural killer cell differentiation (GO:0032823) | 2.35412577 |
| 148 | nitrogen cycle metabolic process (GO:0071941) | 2.34810111 |
| 149 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.34646066 |
| 150 | bile acid biosynthetic process (GO:0006699) | 2.33873339 |
| 151 | carnitine metabolic process (GO:0009437) | 2.32932021 |
| 152 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.32739980 |
| 153 | fructose metabolic process (GO:0006000) | 2.32515103 |
| 154 | negative regulation of blood coagulation (GO:0030195) | 2.31124666 |
| 155 | negative regulation of hemostasis (GO:1900047) | 2.31124666 |
| 156 | regulation of apoptotic cell clearance (GO:2000425) | 2.30405026 |
| 157 | ethanol metabolic process (GO:0006067) | 2.30037231 |
| 158 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.29639561 |
| 159 | glomerular basement membrane development (GO:0032836) | 2.29586402 |
| 160 | embryo implantation (GO:0007566) | 2.28206240 |
| 161 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.27923826 |
| 162 | negative regulation of cell size (GO:0045792) | 2.26123601 |
| 163 | cell-substrate junction assembly (GO:0007044) | 2.24669754 |
| 164 | negative regulation of fatty acid transport (GO:2000192) | 2.23194784 |
| 165 | complement activation (GO:0006956) | 2.22014945 |
| 166 | positive regulation of reactive oxygen species metabolic process (GO:2000379) | 2.21763625 |
| 167 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.20861655 |
| 168 | hyaluronan catabolic process (GO:0030214) | 2.20760137 |
| 169 | atrioventricular valve morphogenesis (GO:0003181) | 2.20141725 |
| 170 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.19838436 |
| 171 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.17011780 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.40816557 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.27137622 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.21184915 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.85193023 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.53147420 |
| 6 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.34376143 |
| 7 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.33554799 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.23534251 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.07129247 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.81001238 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.80557940 |
| 12 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.73328561 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.66284965 |
| 14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.62807410 |
| 15 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.59743193 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.46489122 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.29019293 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.12910471 |
| 19 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.11090262 |
| 20 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.10133470 |
| 21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.09533271 |
| 22 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.03066157 |
| 23 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.00286609 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.97618060 |
| 25 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.96852697 |
| 26 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.96131789 |
| 27 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.93618684 |
| 28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.87927260 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.87907622 |
| 30 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.85270477 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.83243006 |
| 32 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.73295678 |
| 33 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.72945247 |
| 34 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.70670817 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.62262067 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.62201953 |
| 37 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.61462467 |
| 38 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.60635814 |
| 39 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.59002379 |
| 40 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.58608639 |
| 41 | MAF_26560356_Chip-Seq_TH1_Human | 1.52764811 |
| 42 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.52605206 |
| 43 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.51489722 |
| 44 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.50647365 |
| 45 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.47223062 |
| 46 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.45251527 |
| 47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.42619961 |
| 48 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.42207689 |
| 49 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.41124489 |
| 50 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40943324 |
| 51 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.40060661 |
| 52 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.37790805 |
| 53 | CJUN_26792858_Chip-Seq_BT549_Human | 1.36890175 |
| 54 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.32989044 |
| 55 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.29893687 |
| 56 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.28380138 |
| 57 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.27830997 |
| 58 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.26582940 |
| 59 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.26217908 |
| 60 | MYC_22102868_ChIP-Seq_BL_Human | 1.26207129 |
| 61 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.26129953 |
| 62 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.25206449 |
| 63 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.24421151 |
| 64 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23860681 |
| 65 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.23635881 |
| 66 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.23362446 |
| 67 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.23015750 |
| 68 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.20621727 |
| 69 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.19673343 |
| 70 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.19673343 |
| 71 | MYB_26560356_Chip-Seq_TH2_Human | 1.19482922 |
| 72 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.18996292 |
| 73 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.18161659 |
| 74 | P68_20966046_ChIP-Seq_HELA_Human | 1.17623689 |
| 75 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.17556146 |
| 76 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17050563 |
| 77 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.17010340 |
| 78 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.15842068 |
| 79 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.15234965 |
| 80 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.15234965 |
| 81 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.12231037 |
| 82 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.11641110 |
| 83 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.11030956 |
| 84 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.11027963 |
| 85 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.10594877 |
| 86 | MYB_26560356_Chip-Seq_TH1_Human | 1.10022300 |
| 87 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.09421899 |
| 88 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09064484 |
| 89 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.08933288 |
| 90 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08417551 |
| 91 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.07780748 |
| 92 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.07509908 |
| 93 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.06245630 |
| 94 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.06116602 |
| 95 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.06116602 |
| 96 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.04914535 |
| 97 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04622326 |
| 98 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04324759 |
| 99 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.04240653 |
| 100 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.04098041 |
| 101 | UTX_26944678_Chip-Seq_JUKART_Human | 1.03915045 |
| 102 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.03620991 |
| 103 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03284406 |
| 104 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.02701421 |
| 105 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.02546520 |
| 106 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.01959016 |
| 107 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01341933 |
| 108 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.01287502 |
| 109 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.01167356 |
| 110 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.00862618 |
| 111 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.00643909 |
| 112 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.00525738 |
| 113 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.00141469 |
| 114 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99844197 |
| 115 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.99751350 |
| 116 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.99175683 |
| 117 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.98310614 |
| 118 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.97906918 |
| 119 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.97717929 |
| 120 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.96934517 |
| 121 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96575756 |
| 122 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.96276089 |
| 123 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96043180 |
| 124 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.95226314 |
| 125 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.94997738 |
| 126 | SPI1_23127762_ChIP-Seq_K562_Human | 0.93786729 |
| 127 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.93543864 |
| 128 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.93388639 |
| 129 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.92442602 |
| 130 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92001342 |
| 131 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.91768263 |
| 132 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.91722654 |
| 133 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.91344069 |
| 134 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.91323175 |
| 135 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91310896 |
| 136 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.91229880 |
| 137 | ATF3_27146783_Chip-Seq_COLON_Human | 0.89737642 |
| 138 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.87265697 |
| 139 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.86413142 |
| 140 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85358961 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.82133842 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.66909973 |
| 3 | MP0003191_abnormal_cellular_cholesterol | 3.11914820 |
| 4 | MP0005275_abnormal_skin_tensile | 2.88383481 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 2.82329061 |
| 6 | MP0005451_abnormal_body_composition | 2.80642023 |
| 7 | MP0005365_abnormal_bile_salt | 2.53323471 |
| 8 | MP0005360_urolithiasis | 2.51113610 |
| 9 | MP0003279_aneurysm | 2.32102425 |
| 10 | MP0000685_abnormal_immune_system | 2.23372334 |
| 11 | MP0005503_abnormal_tendon_morphology | 2.22790224 |
| 12 | MP0005257_abnormal_intraocular_pressure | 2.11849270 |
| 13 | MP0001958_emphysema | 2.01479815 |
| 14 | MP0003724_increased_susceptibility_to | 1.86471108 |
| 15 | MP0003183_abnormal_peptide_metabolism | 1.85113212 |
| 16 | MP0001835_abnormal_antigen_presentation | 1.80179219 |
| 17 | MP0002877_abnormal_melanocyte_morpholog | 1.79308010 |
| 18 | MP0003806_abnormal_nucleotide_metabolis | 1.77106078 |
| 19 | MP0009840_abnormal_foam_cell | 1.75325358 |
| 20 | MP0003436_decreased_susceptibility_to | 1.74524169 |
| 21 | MP0005085_abnormal_gallbladder_physiolo | 1.73704805 |
| 22 | MP0003950_abnormal_plasma_membrane | 1.70658260 |
| 23 | MP0010329_abnormal_lipoprotein_level | 1.64627141 |
| 24 | MP0003252_abnormal_bile_duct | 1.64415228 |
| 25 | MP0008260_abnormal_autophagy | 1.64216723 |
| 26 | MP0009384_cardiac_valve_regurgitation | 1.63258938 |
| 27 | MP0004130_abnormal_muscle_cell | 1.61661710 |
| 28 | MP0002166_altered_tumor_susceptibility | 1.56800325 |
| 29 | MP0005670_abnormal_white_adipose | 1.56358136 |
| 30 | MP0004858_abnormal_nervous_system | 1.52356951 |
| 31 | MP0001790_abnormal_immune_system | 1.48235450 |
| 32 | MP0005387_immune_system_phenotype | 1.48235450 |
| 33 | MP0000013_abnormal_adipose_tissue | 1.43938317 |
| 34 | MP0005023_abnormal_wound_healing | 1.43781404 |
| 35 | MP0003172_abnormal_lysosome_physiology | 1.43390929 |
| 36 | MP0000749_muscle_degeneration | 1.42567287 |
| 37 | MP0002837_dystrophic_cardiac_calcinosis | 1.42069121 |
| 38 | MP0002933_joint_inflammation | 1.41513940 |
| 39 | MP0009785_altered_susceptibility_to | 1.40785335 |
| 40 | MP0009780_abnormal_chondrocyte_physiolo | 1.40542006 |
| 41 | MP0001853_heart_inflammation | 1.40362726 |
| 42 | MP0003566_abnormal_cell_adhesion | 1.39936105 |
| 43 | MP0005058_abnormal_lysosome_morphology | 1.39461377 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.38800788 |
| 45 | MP0003075_altered_response_to | 1.35648224 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.35343271 |
| 47 | MP0008875_abnormal_xenobiotic_pharmacok | 1.34566423 |
| 48 | MP0005165_increased_susceptibility_to | 1.34191077 |
| 49 | MP0000751_myopathy | 1.33814745 |
| 50 | MP0002060_abnormal_skin_morphology | 1.33366462 |
| 51 | MP0000609_abnormal_liver_physiology | 1.27391052 |
| 52 | MP0001849_ear_inflammation | 1.26697313 |
| 53 | MP0000003_abnormal_adipose_tissue | 1.23324749 |
| 54 | MP0005666_abnormal_adipose_tissue | 1.22833512 |
| 55 | MP0000343_altered_response_to | 1.20932629 |
| 56 | MP0005319_abnormal_enzyme/_coenzyme | 1.19039615 |
| 57 | MP0000858_altered_metastatic_potential | 1.18695041 |
| 58 | MP0001666_abnormal_nutrient_absorption | 1.18638000 |
| 59 | MP0005025_abnormal_response_to | 1.15501820 |
| 60 | MP0008469_abnormal_protein_level | 1.15207232 |
| 61 | MP0002419_abnormal_innate_immunity | 1.13689809 |
| 62 | MP0005083_abnormal_biliary_tract | 1.12812689 |
| 63 | MP0001243_abnormal_dermal_layer | 1.12072201 |
| 64 | MP0001800_abnormal_humoral_immune | 1.11994719 |
| 65 | MP0006082_CNS_inflammation | 1.11849616 |
| 66 | MP0004185_abnormal_adipocyte_glucose | 1.10845370 |
| 67 | MP0005166_decreased_susceptibility_to | 1.10821647 |
| 68 | MP0003091_abnormal_cell_migration | 1.09747143 |
| 69 | MP0005000_abnormal_immune_tolerance | 1.07636315 |
| 70 | MP0004087_abnormal_muscle_fiber | 1.07472159 |
| 71 | MP0010368_abnormal_lymphatic_system | 1.07321502 |
| 72 | MP0005332_abnormal_amino_acid | 1.07175111 |
| 73 | MP0003303_peritoneal_inflammation | 1.06494347 |
| 74 | MP0005623_abnormal_meninges_morphology | 1.05931060 |
| 75 | MP0000604_amyloidosis | 1.05643412 |
| 76 | MP0002006_tumorigenesis | 1.04302627 |
| 77 | MP0002452_abnormal_antigen_presenting | 1.02742416 |
| 78 | MP0002118_abnormal_lipid_homeostasis | 1.02496081 |
| 79 | MP0000750_abnormal_muscle_regeneration | 1.01992276 |
| 80 | MP0005671_abnormal_response_to | 1.01886485 |
| 81 | MP0004272_abnormal_basement_membrane | 1.01463106 |
| 82 | MP0002148_abnormal_hypersensitivity_rea | 1.01373958 |
| 83 | MP0005164_abnormal_response_to | 1.01300097 |
| 84 | MP0009643_abnormal_urine_homeostasis | 0.99547741 |
| 85 | MP0002254_reproductive_system_inflammat | 0.98818792 |
| 86 | MP0009764_decreased_sensitivity_to | 0.97713307 |
| 87 | MP0002971_abnormal_brown_adipose | 0.96931606 |
| 88 | MP0005464_abnormal_platelet_physiology | 0.96246948 |
| 89 | MP0002132_abnormal_respiratory_system | 0.96050947 |
| 90 | MP0004947_skin_inflammation | 0.94944599 |
| 91 | MP0000733_abnormal_muscle_development | 0.94925830 |
| 92 | MP0002723_abnormal_immune_serum | 0.94249760 |
| 93 | MP0002295_abnormal_pulmonary_circulatio | 0.94131033 |
| 94 | MP0002896_abnormal_bone_mineralization | 0.93959297 |
| 95 | MP0000767_abnormal_smooth_muscle | 0.93243654 |
| 96 | MP0000249_abnormal_blood_vessel | 0.92906251 |
| 97 | MP0002998_abnormal_bone_remodeling | 0.92550587 |
| 98 | MP0005390_skeleton_phenotype | 0.91997376 |
| 99 | MP0000678_abnormal_parathyroid_gland | 0.91671390 |
| 100 | MP0003646_muscle_fatigue | 0.91140430 |
| 101 | MP0001845_abnormal_inflammatory_respons | 0.90651160 |
| 102 | MP0005409_darkened_coat_color | 0.89701222 |
| 103 | MP0000747_muscle_weakness | 0.89554501 |
| 104 | MP0005375_adipose_tissue_phenotype | 0.89177529 |
| 105 | MP0009763_increased_sensitivity_to | 0.88692245 |
| 106 | MP0004510_myositis | 0.88235319 |
| 107 | MP0005408_hypopigmentation | 0.87632670 |
| 108 | MP0001661_extended_life_span | 0.87053062 |
| 109 | MP0006054_spinal_hemorrhage | 0.86963022 |
| 110 | MP0000759_abnormal_skeletal_muscle | 0.86287582 |
| 111 | MP0002108_abnormal_muscle_morphology | 0.86158924 |
| 112 | MP0005508_abnormal_skeleton_morphology | 0.84720510 |
| 113 | MP0003186_abnormal_redox_activity | 0.83505330 |
| 114 | MP0005330_cardiomyopathy | 0.83159453 |
| 115 | MP0001542_abnormal_bone_strength | 0.82951764 |
| 116 | MP0001819_abnormal_immune_cell | 0.81856056 |
| 117 | MP0002405_respiratory_system_inflammati | 0.81850802 |
| 118 | MP0002420_abnormal_adaptive_immunity | 0.81811700 |
| 119 | MP0010352_gastrointestinal_tract_polyps | 0.81043970 |
| 120 | MP0002138_abnormal_hepatobiliary_system | 0.80364659 |
| 121 | MP0003045_fibrosis | 0.78987139 |
| 122 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.78542770 |
| 123 | MP0000598_abnormal_liver_morphology | 0.78513014 |
| 124 | MP0002396_abnormal_hematopoietic_system | 0.77762321 |
| 125 | MP0010155_abnormal_intestine_physiology | 0.77441207 |
| 126 | MP0009115_abnormal_fat_cell | 0.77144131 |
| 127 | MP0010630_abnormal_cardiac_muscle | 0.76320594 |
| 128 | MP0002168_other_aberrant_phenotype | 0.76281230 |
| 129 | MP0000681_abnormal_thyroid_gland | 0.75713907 |
| 130 | MP0009278_abnormal_bone_marrow | 0.71154178 |
| 131 | MP0004264_abnormal_extraembryonic_tissu | 0.70892449 |
| 132 | MP0003868_abnormal_feces_composition | 0.70715976 |
| 133 | MP0009333_abnormal_splenocyte_physiolog | 0.70441872 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 4.85402825 |
| 2 | Premature rupture of membranes (HP:0001788) | 4.42198762 |
| 3 | Type 1 muscle fiber predominance (HP:0003803) | 3.66824707 |
| 4 | Increased connective tissue (HP:0009025) | 3.59897954 |
| 5 | Peritonitis (HP:0002586) | 3.40806267 |
| 6 | Aortic dissection (HP:0002647) | 3.21624444 |
| 7 | Deep venous thrombosis (HP:0002625) | 3.07315211 |
| 8 | Myocardial infarction (HP:0001658) | 3.02083249 |
| 9 | Xanthomatosis (HP:0000991) | 3.01985466 |
| 10 | Complement deficiency (HP:0004431) | 3.00009849 |
| 11 | Aortic aneurysm (HP:0004942) | 2.98591895 |
| 12 | Broad metatarsal (HP:0001783) | 2.82290740 |
| 13 | Distal lower limb muscle weakness (HP:0009053) | 2.81768578 |
| 14 | Vertebral compression fractures (HP:0002953) | 2.80931235 |
| 15 | Muscle fiber inclusion bodies (HP:0100299) | 2.74424567 |
| 16 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.73322222 |
| 17 | Dysostosis multiplex (HP:0000943) | 2.72834662 |
| 18 | Vascular tortuosity (HP:0004948) | 2.72833558 |
| 19 | Abnormality of complement system (HP:0005339) | 2.70984797 |
| 20 | Ankle contracture (HP:0006466) | 2.66709430 |
| 21 | Cerebral aneurysm (HP:0004944) | 2.56720811 |
| 22 | Osteolytic defects of the hand bones (HP:0009699) | 2.56401642 |
| 23 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.56401642 |
| 24 | Round ear (HP:0100830) | 2.52067311 |
| 25 | Arterial tortuosity (HP:0005116) | 2.51545508 |
| 26 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.48813331 |
| 27 | Hypoalphalipoproteinemia (HP:0003233) | 2.45190295 |
| 28 | Joint stiffness (HP:0001387) | 2.42979981 |
| 29 | Systemic lupus erythematosus (HP:0002725) | 2.41040861 |
| 30 | Glucose intolerance (HP:0000833) | 2.39982391 |
| 31 | Hemorrhage of the eye (HP:0011885) | 2.38535478 |
| 32 | Dilatation of the ascending aorta (HP:0005111) | 2.37924031 |
| 33 | Cervical subluxation (HP:0003308) | 2.37513390 |
| 34 | Nemaline bodies (HP:0003798) | 2.36870025 |
| 35 | Mucopolysacchariduria (HP:0008155) | 2.34429199 |
| 36 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.34429199 |
| 37 | Mitral stenosis (HP:0001718) | 2.33429655 |
| 38 | Hyperlipoproteinemia (HP:0010980) | 2.28490667 |
| 39 | Abnormality of the common coagulation pathway (HP:0010990) | 2.28413921 |
| 40 | Ectopia lentis (HP:0001083) | 2.27303836 |
| 41 | Biconcave vertebral bodies (HP:0004586) | 2.26859645 |
| 42 | Spinal rigidity (HP:0003306) | 2.25584686 |
| 43 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.24856317 |
| 44 | Muscle fiber splitting (HP:0003555) | 2.24480161 |
| 45 | Bladder diverticulum (HP:0000015) | 2.24306539 |
| 46 | Exercise-induced muscle cramps (HP:0003710) | 2.23123902 |
| 47 | Hyporeflexia of lower limbs (HP:0002600) | 2.22088138 |
| 48 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.20745650 |
| 49 | Autoimmune thrombocytopenia (HP:0001973) | 2.19983904 |
| 50 | Purpura (HP:0000979) | 2.17938246 |
| 51 | Abnormality of the peritoneum (HP:0002585) | 2.17245125 |
| 52 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.15787568 |
| 53 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.15787568 |
| 54 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.15787568 |
| 55 | Spondylolisthesis (HP:0003302) | 2.14934604 |
| 56 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.14297090 |
| 57 | Ulnar deviation of the wrist (HP:0003049) | 2.14139681 |
| 58 | Amyloidosis (HP:0011034) | 2.13445999 |
| 59 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.12794804 |
| 60 | Distal upper limb amyotrophy (HP:0007149) | 2.12284614 |
| 61 | Upper limb amyotrophy (HP:0009129) | 2.12284614 |
| 62 | Soft skin (HP:0000977) | 2.12133049 |
| 63 | Blue sclerae (HP:0000592) | 2.12113402 |
| 64 | Absent phalangeal crease (HP:0006109) | 2.11220105 |
| 65 | Intrahepatic cholestasis (HP:0001406) | 2.11115419 |
| 66 | Slender build (HP:0001533) | 2.11046454 |
| 67 | Myoglobinuria (HP:0002913) | 2.10036984 |
| 68 | Distal arthrogryposis (HP:0005684) | 2.08777227 |
| 69 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.07078050 |
| 70 | Atrophic scars (HP:0001075) | 2.05790231 |
| 71 | Shallow orbits (HP:0000586) | 2.04395340 |
| 72 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.04227187 |
| 73 | Eczematoid dermatitis (HP:0000976) | 2.04028623 |
| 74 | Exercise-induced myalgia (HP:0003738) | 2.03868077 |
| 75 | Hyperacusis (HP:0010780) | 2.03497204 |
| 76 | Increased variability in muscle fiber diameter (HP:0003557) | 2.02975293 |
| 77 | Mitral valve prolapse (HP:0001634) | 2.02947394 |
| 78 | Right ventricular cardiomyopathy (HP:0011663) | 2.02875095 |
| 79 | Abnormality of the Achilles tendon (HP:0005109) | 2.02756401 |
| 80 | Vascular calcification (HP:0004934) | 2.01944233 |
| 81 | Abnormal delivery (HP:0001787) | 2.01924796 |
| 82 | Abnormal cartilage morphology (HP:0002763) | 2.01312420 |
| 83 | Nephritis (HP:0000123) | 2.01221610 |
| 84 | Hydroxyprolinuria (HP:0003080) | 2.01018181 |
| 85 | Abnormality of proline metabolism (HP:0010907) | 2.01018181 |
| 86 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.00696215 |
| 87 | Follicular hyperkeratosis (HP:0007502) | 2.00290539 |
| 88 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.99921411 |
| 89 | Difficulty running (HP:0009046) | 1.98980135 |
| 90 | Thin bony cortex (HP:0002753) | 1.98824027 |
| 91 | Abnormal gallbladder physiology (HP:0012438) | 1.98780744 |
| 92 | Cholecystitis (HP:0001082) | 1.98780744 |
| 93 | Short nail (HP:0001799) | 1.97715063 |
| 94 | Achilles tendon contracture (HP:0001771) | 1.95335374 |
| 95 | Elbow flexion contracture (HP:0002987) | 1.95225483 |
| 96 | Asymmetric septal hypertrophy (HP:0001670) | 1.93931881 |
| 97 | Rhabdomyolysis (HP:0003201) | 1.93198210 |
| 98 | Gastrointestinal stroma tumor (HP:0100723) | 1.92820807 |
| 99 | Fragile skin (HP:0001030) | 1.92256435 |
| 100 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.92032535 |
| 101 | Hypolipoproteinemia (HP:0010981) | 1.91707227 |
| 102 | Abnormality of carpal bone ossification (HP:0006257) | 1.89306118 |
| 103 | Aneurysm (HP:0002617) | 1.89285173 |
| 104 | Abnormal glucose tolerance (HP:0001952) | 1.88695888 |
| 105 | Beaking of vertebral bodies (HP:0004568) | 1.88290264 |
| 106 | Abnormality of the acetabulum (HP:0003170) | 1.88218893 |
| 107 | Abnormality of dentin (HP:0010299) | 1.88073823 |
| 108 | Emphysema (HP:0002097) | 1.87974760 |
| 109 | Wormian bones (HP:0002645) | 1.87915701 |
| 110 | Abnormality of the nasal mucosa (HP:0000433) | 1.87662334 |
| 111 | Difficulty climbing stairs (HP:0003551) | 1.85799387 |
| 112 | Hyperammonemia (HP:0001987) | 1.85105797 |
| 113 | Glomerulonephritis (HP:0000099) | 1.84715769 |
| 114 | Growth hormone excess (HP:0000845) | 1.84446363 |
| 115 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.83927461 |
| 116 | Coxa vara (HP:0002812) | 1.83194342 |
| 117 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.82480713 |
| 118 | Prolonged partial thromboplastin time (HP:0003645) | 1.82327732 |
| 119 | Myopathic facies (HP:0002058) | 1.81949147 |
| 120 | Cardiovascular calcification (HP:0011915) | 1.81904599 |
| 121 | Increased mean platelet volume (HP:0011877) | 1.81442203 |
| 122 | Hypertriglyceridemia (HP:0002155) | 1.81090182 |
| 123 | Interstitial pulmonary disease (HP:0006530) | 1.79811229 |
| 124 | Acanthosis nigricans (HP:0000956) | 1.79581065 |
| 125 | Facial diplegia (HP:0001349) | 1.79174585 |
| 126 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.79140624 |
| 127 | Hyperglycinuria (HP:0003108) | 1.79090595 |
| 128 | Abnormality of the intrinsic pathway (HP:0010989) | 1.78622938 |
| 129 | Epidermoid cyst (HP:0200040) | 1.78074389 |
| 130 | Colitis (HP:0002583) | 1.76958207 |
| 131 | Ketosis (HP:0001946) | 1.76949563 |
| 132 | Malnutrition (HP:0004395) | 1.76339238 |
| 133 | Lipoatrophy (HP:0100578) | 1.76130799 |
| 134 | Joint hemorrhage (HP:0005261) | 1.75975013 |
| 135 | Generalized amyotrophy (HP:0003700) | 1.75707024 |
| 136 | Camptodactyly of toe (HP:0001836) | 1.75527763 |
| 137 | Alopecia of scalp (HP:0002293) | 1.75234834 |
| 138 | EMG: myopathic abnormalities (HP:0003458) | 1.75027814 |
| 139 | Skin nodule (HP:0200036) | 1.74869427 |
| 140 | Distal lower limb amyotrophy (HP:0008944) | 1.74633415 |
| 141 | Chronic otitis media (HP:0000389) | 1.74454354 |
| 142 | Ovoid vertebral bodies (HP:0003300) | 1.74417325 |
| 143 | Abnormality of iron homeostasis (HP:0011031) | 1.74285221 |
| 144 | Aortic regurgitation (HP:0001659) | 1.73286180 |
| 145 | Mitral regurgitation (HP:0001653) | 1.71007712 |
| 146 | Abnormality of glycolipid metabolism (HP:0010969) | 1.70263812 |
| 147 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.70263812 |
| 148 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.70263812 |
| 149 | Fatigue (HP:0012378) | 1.70194929 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 3.70673476 |
| 2 | TRIB3 | 3.67087738 |
| 3 | ERN1 | 3.55458033 |
| 4 | PRPF4B | 3.10443354 |
| 5 | TESK1 | 2.81083645 |
| 6 | PKN2 | 2.60002140 |
| 7 | FGFR4 | 2.47001746 |
| 8 | TYK2 | 2.42783523 |
| 9 | MAP4K1 | 2.30139280 |
| 10 | EPHA2 | 2.25751743 |
| 11 | SIK1 | 2.23187608 |
| 12 | MAP2K3 | 2.18880706 |
| 13 | TBK1 | 2.07907233 |
| 14 | MUSK | 2.06710554 |
| 15 | ICK | 2.01498371 |
| 16 | KIT | 1.99848904 |
| 17 | BCKDK | 1.98480310 |
| 18 | JAK3 | 1.91113030 |
| 19 | SMG1 | 1.91107419 |
| 20 | JAK1 | 1.83263618 |
| 21 | NEK9 | 1.82211186 |
| 22 | MAP3K14 | 1.74976479 |
| 23 | LIMK1 | 1.74021591 |
| 24 | FLT3 | 1.68470713 |
| 25 | IKBKB | 1.62035882 |
| 26 | SCYL2 | 1.55994690 |
| 27 | PIK3CG | 1.55978698 |
| 28 | TGFBR2 | 1.49403472 |
| 29 | PTK6 | 1.49078880 |
| 30 | LRRK2 | 1.47642753 |
| 31 | IKBKE | 1.47113604 |
| 32 | TESK2 | 1.43559016 |
| 33 | PDGFRA | 1.42779265 |
| 34 | PIK3CA | 1.42484620 |
| 35 | MAP3K12 | 1.40800270 |
| 36 | TRPM7 | 1.37563325 |
| 37 | EPHB1 | 1.36377434 |
| 38 | PIM2 | 1.35680847 |
| 39 | ZAP70 | 1.34531414 |
| 40 | EPHA3 | 1.34284807 |
| 41 | MAP3K6 | 1.31805875 |
| 42 | MST1R | 1.31424047 |
| 43 | OBSCN | 1.30248733 |
| 44 | NME2 | 1.29113149 |
| 45 | ARAF | 1.24895961 |
| 46 | RIPK1 | 1.24341485 |
| 47 | DDR2 | 1.22915575 |
| 48 | PRKD2 | 1.22446901 |
| 49 | PAK4 | 1.22442054 |
| 50 | MYLK | 1.21563764 |
| 51 | FGFR3 | 1.21256824 |
| 52 | MAP3K7 | 1.14388140 |
| 53 | CAMK1D | 1.11406412 |
| 54 | CSF1R | 1.09331528 |
| 55 | STK10 | 1.07365637 |
| 56 | RIPK4 | 1.05691928 |
| 57 | CDC42BPA | 1.03944493 |
| 58 | MAP3K3 | 1.02880399 |
| 59 | PRKD3 | 1.00039899 |
| 60 | CSK | 0.95786145 |
| 61 | KDR | 0.95707351 |
| 62 | DMPK | 0.93600729 |
| 63 | MAP3K1 | 0.90093722 |
| 64 | EEF2K | 0.89262215 |
| 65 | BLK | 0.86313440 |
| 66 | BMX | 0.84306189 |
| 67 | IRAK3 | 0.83804194 |
| 68 | RPS6KA4 | 0.83220363 |
| 69 | JAK2 | 0.81180688 |
| 70 | MAP3K10 | 0.81126244 |
| 71 | TAOK3 | 0.80810160 |
| 72 | PAK2 | 0.80476184 |
| 73 | PDPK1 | 0.79447500 |
| 74 | HCK | 0.77135939 |
| 75 | ITK | 0.76734859 |
| 76 | IRAK4 | 0.75806122 |
| 77 | DAPK1 | 0.74563813 |
| 78 | NLK | 0.73993689 |
| 79 | MAPK11 | 0.73691820 |
| 80 | TXK | 0.71105739 |
| 81 | MOS | 0.70779096 |
| 82 | MAPK12 | 0.69919570 |
| 83 | HIPK2 | 0.69007919 |
| 84 | MAP3K13 | 0.68432029 |
| 85 | NTRK1 | 0.68419477 |
| 86 | PRKAA2 | 0.68266801 |
| 87 | TEC | 0.67897396 |
| 88 | FRK | 0.67433319 |
| 89 | BTK | 0.66175382 |
| 90 | MAPK7 | 0.65059075 |
| 91 | RPS6KA2 | 0.64795212 |
| 92 | GRK6 | 0.63415627 |
| 93 | LCK | 0.62506443 |
| 94 | ILK | 0.61778495 |
| 95 | STK38 | 0.60843328 |
| 96 | ROCK1 | 0.60337803 |
| 97 | CHUK | 0.59898385 |
| 98 | MAP3K2 | 0.58358561 |
| 99 | PDGFRB | 0.58101946 |
| 100 | ABL2 | 0.57523152 |
| 101 | BMPR2 | 0.55438224 |
| 102 | PHKG2 | 0.54793238 |
| 103 | PHKG1 | 0.54793238 |
| 104 | PDK2 | 0.54690880 |
| 105 | PRKG2 | 0.52764164 |
| 106 | PDK3 | 0.50226963 |
| 107 | PDK4 | 0.50226963 |
| 108 | CDK6 | 0.49791960 |
| 109 | PTK2 | 0.49103244 |
| 110 | SYK | 0.48306624 |
| 111 | PRKCH | 0.48051446 |
| 112 | DAPK3 | 0.47897068 |
| 113 | CAMK1G | 0.47396688 |
| 114 | PIM1 | 0.47113968 |
| 115 | MAPK4 | 0.46718547 |
| 116 | MET | 0.46331039 |
| 117 | MAP3K11 | 0.45587239 |
| 118 | PRKD1 | 0.45557520 |
| 119 | PTK2B | 0.45430015 |
| 120 | MAP2K1 | 0.45302881 |
| 121 | MAPKAPK2 | 0.44024927 |
| 122 | ABL1 | 0.43503999 |
| 123 | TAOK2 | 0.43131028 |
| 124 | PDK1 | 0.41225254 |
| 125 | IGF1R | 0.41210860 |
| 126 | SIK3 | 0.41128583 |
| 127 | TAOK1 | 0.39647023 |
| 128 | LMTK2 | 0.39427654 |
| 129 | CAMK2G | 0.39400733 |
| 130 | MTOR | 0.38824300 |
| 131 | LATS1 | 0.38460508 |
| 132 | MAP3K8 | 0.37977203 |
| 133 | MAPKAPK3 | 0.37916197 |
| 134 | RET | 0.37160509 |
| 135 | GRK5 | 0.37138674 |
| 136 | MAP2K2 | 0.36498797 |
| 137 | LATS2 | 0.35882741 |
| 138 | EIF2AK1 | 0.35835351 |
| 139 | MARK2 | 0.34318247 |
| 140 | AKT3 | 0.33846622 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.13057908 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.63352754 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.57857522 |
| 4 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.40311290 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.35185059 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.30407144 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.28169064 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.27924892 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.21072812 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.12650806 |
| 11 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.11164658 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.06885188 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.96719280 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.95159489 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.87442668 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.86870594 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.84668020 |
| 18 | Galactose metabolism_Homo sapiens_hsa00052 | 1.73690458 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.59462120 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.56248173 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52998977 |
| 22 | Malaria_Homo sapiens_hsa05144 | 1.45647886 |
| 23 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.44565389 |
| 24 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.41997122 |
| 25 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.34867852 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.34423343 |
| 27 | Leishmaniasis_Homo sapiens_hsa05140 | 1.30225415 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.27703346 |
| 29 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.26490900 |
| 30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.21872263 |
| 31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.20570393 |
| 32 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.20567935 |
| 33 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.19380483 |
| 34 | Carbon metabolism_Homo sapiens_hsa01200 | 1.14579326 |
| 35 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.14574564 |
| 36 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.08165640 |
| 37 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.08052284 |
| 38 | Allograft rejection_Homo sapiens_hsa05330 | 1.06010898 |
| 39 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.05391607 |
| 40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.05126799 |
| 41 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.02623499 |
| 42 | Prion diseases_Homo sapiens_hsa05020 | 1.02489085 |
| 43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.98694474 |
| 44 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.96624820 |
| 45 | Focal adhesion_Homo sapiens_hsa04510 | 0.95939044 |
| 46 | Insulin resistance_Homo sapiens_hsa04931 | 0.95905545 |
| 47 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.94810076 |
| 48 | Histidine metabolism_Homo sapiens_hsa00340 | 0.94636459 |
| 49 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.94619197 |
| 50 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.93875018 |
| 51 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.93610603 |
| 52 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.93367167 |
| 53 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.93298428 |
| 54 | Asthma_Homo sapiens_hsa05310 | 0.93258197 |
| 55 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.92986933 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.91688855 |
| 57 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.91540153 |
| 58 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.91060931 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89477060 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 0.89425271 |
| 61 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.88305585 |
| 62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86822369 |
| 63 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.85703567 |
| 64 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.85693131 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 0.85149450 |
| 66 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.82710310 |
| 67 | Pertussis_Homo sapiens_hsa05133 | 0.82477813 |
| 68 | Measles_Homo sapiens_hsa05162 | 0.79310391 |
| 69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.77778148 |
| 70 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.77491430 |
| 71 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.77343380 |
| 72 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.75436385 |
| 73 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.75211090 |
| 74 | Sulfur relay system_Homo sapiens_hsa04122 | 0.75023468 |
| 75 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.73818277 |
| 76 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.73079036 |
| 77 | Bile secretion_Homo sapiens_hsa04976 | 0.72495155 |
| 78 | Lysine degradation_Homo sapiens_hsa00310 | 0.71324994 |
| 79 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.70459119 |
| 80 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.69660932 |
| 81 | Retinol metabolism_Homo sapiens_hsa00830 | 0.69470868 |
| 82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.69187332 |
| 83 | Tuberculosis_Homo sapiens_hsa05152 | 0.69073321 |
| 84 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.68705059 |
| 85 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.68534854 |
| 86 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66280739 |
| 87 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.66103167 |
| 88 | Other glycan degradation_Homo sapiens_hsa00511 | 0.66001924 |
| 89 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.65779645 |
| 90 | Influenza A_Homo sapiens_hsa05164 | 0.64234028 |
| 91 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.63956692 |
| 92 | Platelet activation_Homo sapiens_hsa04611 | 0.63929800 |
| 93 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.63505479 |
| 94 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63358894 |
| 95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.63042924 |
| 96 | Lysosome_Homo sapiens_hsa04142 | 0.62193404 |
| 97 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.61430818 |
| 98 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61026631 |
| 99 | Legionellosis_Homo sapiens_hsa05134 | 0.60988743 |
| 100 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.60966680 |
| 101 | Shigellosis_Homo sapiens_hsa05131 | 0.59548989 |
| 102 | Mineral absorption_Homo sapiens_hsa04978 | 0.59455042 |
| 103 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.58780646 |
| 104 | Bladder cancer_Homo sapiens_hsa05219 | 0.58750430 |
| 105 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.58630144 |
| 106 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.57310861 |
| 107 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.56363154 |
| 108 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55882952 |
| 109 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.55749224 |
| 110 | Hepatitis C_Homo sapiens_hsa05160 | 0.55607504 |
| 111 | * Apoptosis_Homo sapiens_hsa04210 | 0.54928611 |
| 112 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.54916303 |
| 113 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54652595 |
| 114 | Endocytosis_Homo sapiens_hsa04144 | 0.54572830 |
| 115 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.54562292 |
| 116 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53413443 |
| 117 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53404042 |
| 118 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.52662402 |
| 119 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.52214986 |
| 120 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51480994 |
| 121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.51414847 |
| 122 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.50909347 |
| 123 | Phagosome_Homo sapiens_hsa04145 | 0.50726420 |
| 124 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.50120079 |
| 125 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.49492485 |
| 126 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.49115207 |
| 127 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.47187402 |
| 128 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.47156642 |
| 129 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.46402963 |
| 130 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.46015975 |
| 131 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39272159 |

